LAVA Therapeutics Ownership | Who Owns LAVA Therapeutics?
LAVA Therapeutics Ownership Summary
LAVA Therapeutics is owned by 29.91% institutional investors, 32.69% insiders, and 37.39% retail investors. Redmile group is the largest institutional shareholder, holding 7.73% of LVTX shares. Bruce is the top mutual fund, with 1.98% of its assets in LAVA Therapeutics shares.
LVTX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | LAVA Therapeutics | 29.91% | 32.69% | 37.39% |
Sector | Healthcare Stocks | 279.17% | 10.51% | -189.68% |
Industry | Biotech Stocks | 63.95% | 10.67% | 25.38% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Redmile group | 2.07M | 7.73% | $1.97M |
Sanofi | 1.92M | 7.15% | $1.83M |
Merck | 1.15M | 4.28% | $1.09M |
Bruce | 771.87K | 2.88% | $733.28K |
Sphera funds management | 126.33K | 0.47% | $120.14K |
Pathway financial advisors | 102.50K | 0.38% | $97.48K |
Pnc financial services group | 65.00K | 0.24% | $61.81K |
Two sigma investments, lp | 48.77K | 0.18% | $46.38K |
Bnp paribas arbitrage, snc | 41.80K | 0.16% | $39.75K |
Ubs group | 18.43K | 0.07% | $17.53K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Sanofi | 1.92M | 1.05% | $1.83M |
Merck | 1.15M | 0.42% | $1.09M |
Bruce | 771.87K | 0.24% | $733.28K |
Redmile group | 2.07M | 0.14% | $1.97M |
Pathway financial advisors | 102.50K | 0.02% | $97.48K |
Sphera funds management | 126.33K | 0.02% | $120.14K |
Two sigma investments, lp | 48.77K | 0.00% | $46.38K |
Susquehanna group, llp | - | - | - |
Two sigma securities | - | - | - |
Engineers gate manager lp | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Sanofi | 1.92M | 1.05% | 1.92M |
Merck | 1.15M | 0.42% | 1.15M |
Bnp paribas arbitrage, snc | 41.80K | - | 41.80K |
Ubs group | 18.43K | - | 17.36K |
Morgan stanley | 15.60K | - | 5.40K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Alpha wave global, lp | - | - | -87.40K |
Two sigma investments, lp | 48.77K | 0.00% | -53.99K |
Tang capital management | - | - | -53.10K |
Susquehanna group, llp | - | - | -48.20K |
Engineers gate manager lp | - | - | -31.98K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Sanofi | 1.92M | 1.05% | 1.92M | $1.83M |
Merck | 1.15M | 0.42% | 1.15M | $1.09M |
Bnp paribas arbitrage, snc | 41.80K | - | 41.80K | $39.75K |
Sold Out
Holder | Change |
---|---|
Northwestern mutual wealth management | -20.00 |
Tsfg | -400.00 |
Simplex trading | -2.59K |
Cibc private wealth group | -6.00K |
Two sigma securities | -13.16K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 21 | - | 8,044,890 | 24.29% | 29 | 5.15% | 10 | -23.08% | 3 | - |
Dec 31, 2024 | 21 | -8.70% | 6,472,867 | 79.38% | 24 | 13.32% | 13 | 116.67% | 3 | -57.14% |
Sep 30, 2024 | 23 | 9.52% | 3,608,399 | -3.99% | 13 | 6.84% | 6 | -33.33% | 7 | 133.33% |
Jun 30, 2024 | 21 | -8.70% | 3,758,209 | -0.08% | 14 | 7.11% | 9 | -30.77% | 3 | - |
Mar 31, 2024 | 23 | 64.29% | 3,761,071 | -35.55% | 14 | 2.85% | 13 | 225.00% | 3 | -25.00% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Bruce | 521.87K | 1.98% | -250.00K |
Evli Hannibal | 156.83K | 0.60% | - |
Mutual Fund Evli Hannibal | 156.83K | 0.60% | - |
Mandarine Global Microcap G EUR | 27.50K | 0.10% | - |
Fidelity Nasdaq Composite Index | 16.16K | 0.06% | - |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | - |
LVTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools